)

Akoya Biosciences (AKYA) investor relations material
Akoya Biosciences Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
AI-driven spatial profiling and clinical application
AI-powered analysis of trillions of immune cell data points identified key predictors of cancer recurrence risk, focusing on spatial distribution and single-cell resolution.
Developed an AI strategy to filter massive datasets into a few clinically relevant biomarkers, enabling explainable and visualizable predictions at the single-cell level.
Introduced the concept of H&E 2.0, leveraging AI and cloud-based tools to enhance traditional pathology and streamline clinical trial recruitment.
AI-enabled virtual staining and immune scoring systems outperformed traditional prognostic factors in predicting liver cancer recurrence.
Human expertise remains integral in AI decision-making, ensuring clinical relevance and safety.
Key research findings and validation
Identified a five-gene immune signature, primarily involving NK cells, that accurately stratifies liver cancer patients by recurrence risk.
Immune scoring system based on these markers achieved an accuracy (AUC) of 0.82, surpassing existing clinical predictors.
Ex vivo and in vivo experiments confirmed the mechanistic role of NK cells and their interaction with CD8 T cells in tumor control.
High immune scores correlated with better response to immunotherapy, converting high-risk patients to favorable outcomes.
Spatial proteomics and mass spectrometry approaches revealed additional protein markers, including unannotated "dark proteins."
Future directions and broader impact
Ongoing work aims to automate image quantification and reporting for multiplexed assays, making clinical translation more efficient.
Efforts are underway to generalize the AI-driven scoring system for broader clinical and global health applications, including resource-limited settings.
The team is advancing H&E 2.0 and exploring further improvements, such as cloud-based platforms and new biomarker panels.
Emphasis on rigorous validation across technologies and settings to ensure findings are robust and biologically meaningful.
Encouragement for early-career scientists to persist, collaborate, and maintain integrity in research.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage